Effects of growth hormone antagonists on 3T3-F442A preadipocyte differentiation. 1995

B C Xu, and W Y Chen, and T Gu, and D Ridgway, and P Wiehl, and S Okada, and J J Kopchick
Department of Biological Sciences, Ohio University, Athens 45701, USA.

We have previously shown that a bovine (b) GH antagonist, bGH-M8, which possesses three amino acid substitutions in its third alpha-helix, inhibits mouse 3T3-F442A preadipocyte differentiation. In the current studies, we used the bGH and human (h) GH analogs with single amino acid substitution, bGH-G119R and hGH-G120R, for determining their biological activity using the preadipocyte differentiation assay. Short-term and long-term GH-inducible events were studied during adipose differentiation, including late marker gene expression (adipocyte protein 2), immediate early gene induction (c-fos), and tyrosine phosphorylation of intracellular proteins. The results demonstrated that these GH analogs not only failed to induce these three events, but also antagonized GH induction of c-fos expression and phosphorylation of proteins of apparent molecular mass of 95 kDa. Our present study agrees with the notion that GH must bind to the GH receptor via site one and with a second GH receptor molecule (or with some yet unidentified 'second target') through GH binding site two. This interaction is important for subsequent GH-dependent biological events.

UI MeSH Term Description Entries
D007424 Intracellular Fluid The fluid inside CELLS. Fluid, Intracellular,Fluids, Intracellular,Intracellular Fluids
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005227 Fatty Acids Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed) Aliphatic Acid,Esterified Fatty Acid,Fatty Acid,Fatty Acids, Esterified,Fatty Acids, Saturated,Saturated Fatty Acid,Aliphatic Acids,Acid, Aliphatic,Acid, Esterified Fatty,Acid, Saturated Fatty,Esterified Fatty Acids,Fatty Acid, Esterified,Fatty Acid, Saturated,Saturated Fatty Acids

Related Publications

B C Xu, and W Y Chen, and T Gu, and D Ridgway, and P Wiehl, and S Okada, and J J Kopchick
May 2012, Journal of medicinal food,
B C Xu, and W Y Chen, and T Gu, and D Ridgway, and P Wiehl, and S Okada, and J J Kopchick
November 1988, Cytotechnology,
B C Xu, and W Y Chen, and T Gu, and D Ridgway, and P Wiehl, and S Okada, and J J Kopchick
March 1987, Biochemistry and cell biology = Biochimie et biologie cellulaire,
B C Xu, and W Y Chen, and T Gu, and D Ridgway, and P Wiehl, and S Okada, and J J Kopchick
October 1990, Proceedings of the National Academy of Sciences of the United States of America,
B C Xu, and W Y Chen, and T Gu, and D Ridgway, and P Wiehl, and S Okada, and J J Kopchick
May 1988, Endocrinology,
B C Xu, and W Y Chen, and T Gu, and D Ridgway, and P Wiehl, and S Okada, and J J Kopchick
May 1995, Biochemical Society transactions,
B C Xu, and W Y Chen, and T Gu, and D Ridgway, and P Wiehl, and S Okada, and J J Kopchick
August 1988, Endocrinology,
B C Xu, and W Y Chen, and T Gu, and D Ridgway, and P Wiehl, and S Okada, and J J Kopchick
April 1990, Biochemical medicine and metabolic biology,
B C Xu, and W Y Chen, and T Gu, and D Ridgway, and P Wiehl, and S Okada, and J J Kopchick
November 1997, Biochemical Society transactions,
B C Xu, and W Y Chen, and T Gu, and D Ridgway, and P Wiehl, and S Okada, and J J Kopchick
November 1993, Biochemical Society transactions,
Copied contents to your clipboard!